INTRODUCTION
Retinopathy of prematurity (ROP) is a potentially blinding condition affecting infants with incompletely vascularized retinas. ROP is reported to develop in 84% of premature survivors born at <28 weeks gestation. 1 Normally, retinal vascular development progresses from the 16th week of gestation to the 40th week in a central to peripheral wave at a rate of about 0.1 mm/day. 2 ROP alters this normal developmental progression, which instead follows a two-staged pathophysiologic course: an initial phase of vasoconstriction and arrested vessel growth, followed by a second phase of abnormal vessel proliferation. The onset of ROP generally requires two conditions. The first is incomplete retinal vascular development. ROP incidence and severity are directly proportional to the degree of prematurity F that is, ROP outcome correlates with the size of the area of retinal avascularity at onset. [3] [4] [5] [6] The second condition involves exposure of the developing retina to an abnormal environmental influence and several have been suggested. 7 Most prominent among these is retinal hyperoxia resulting from postnatal hyperoxemia in infants receiving supplemental oxygen to compensate for inadequate pulmonary function. This condition, alone or in combination with other as yet unidentified insults, leads to cessation of retinal vessel development. The retinal vasculature then enters a quiescent phase for days or weeks, while the formation of a ridge-like structure develops, separating the central vascularized region of the retina from the peripheral avascular region. This structure, which is pathognomic of ROP, histologically consists of mesenchymal and endothelial cells. Concomitant development of the retinal neurons with advancing postnatal age results in increasing oxygen requirements, which cannot be met by the attenuated vessel compliment, resulting in retinal hypoxia. 8 As a result of hypoxia or another as yet undefined stimulus, angiogenic growth factor induction occurs, followed by rapid growth of new vessels within the ridge. The new vessels can regress by involution and remodeling into a nearly normal vascular pattern or the growth can progress to extraretinal neovascularization. 9 These extraretinal vessels are weak and prone to leakage. The result is vitreous hemorrhage, scarring and contraction, leading to retinal folds or detachments and vision loss. 10 The series of events described in the preceding paragraphs builds upon the well-documented association between extended oxygen therapy and negative ROP outcome. 11 And, while the historical importance of excessive oxygen cannot be overstated, its precise role in the etiology of ROP remains largely undefined. For example, some infants with well-documented ROP never received supplemental oxygen, and many infants with documented severe hyperoxemia never developed ROP. 12 Despite the lack of information on the precise role of oxygen in the etiology of ROP, a number of studies have documented the importance of factors related to therapeutic use of oxygen. [13] [14] [15] [16] [17] [18] [19] One especially important factor is partial pressure of dissolved arterial oxygen (PaO 2 ) fluctuation, which has been associated in both clinical [20] [21] [22] and animal [23] [24] [25] studies with the development of ROP. The partial pressure of oxygen in arterial blood can fluctuate rapidly in sick premature infants, leading to alternating episodes of severe and extended hyperoxemia and hypoxemia. Frequently, these events are related to the infants' underlying disease, but they may also be simply the result of routine medical and nursing intervention.
In carefully controlled experiments conducted in newborn rats, we demonstrated that PaO 2 fluctuations play a principal role in the development of abnormal retinal vessel growth upon removal of the animal to room air. [23] [24] [25] Fluctuating oxygen was more damaging than constant exposure, even when the cumulative oxygen delivered to the rat pups was considerably less. Moreover, the degree of fluctuation was positively and strongly correlated to the extent of retinal vascular pathology. In this study, we seek to determine the relevance of this experimental finding to the clinical setting, using a retrospective review of infant blood gas profiles.
METHODS

Study Design
This retrospective cohort study included infants weighing 1500 g or less at birth admitted to Arkansas Children's Hospital (Little Rock, AR) neonatal intensive care unit within the first 2 days of life between January 1, 1993 and June 30, 1995. Owing to the nature of this study (retrospective chart review with no identifying information), the Institutional Review Board waived consent. We studied only infants who lived for 6 weeks or longer and had their highest active stage of ROP documented. Among 257 surviving infants, 24 were discharged before examination and two were discharged during ROP progression. For all other infants, both eyes were initially examined between 4 and 6 weeks after birth by a board-certified ophthalmologist specializing in pediatric or vitreoretinal diseases using indirect ophthalmoscopy. Thereafter, subsequent eye examinations were performed weekly or biweekly depending on the severity of the eye disease until complete vascularization of the retinas was achieved. The highest stage of ROP was recorded using the International Classification of Retinopathy of Prematurity (ICROP), with the exception that infants with zone 1 ROP of any stage less than threshold or with zone 2 ROP at Stage 2 þ were included in the prethreshold group. 26 Eyes were diagnosed as prethreshold or threshold ROP precisely according to the criteria used in the multicenter trial of cryotherapy for retinopathy of prematurity (CRYO-ROP). 27 Before an eye was diagnosed with threshold ROP, a second examiner was required to confirm independently the diagnosis at a separate eye examination. Demographic factors and other clinical variables assessed included birth weight, gestational age (determined by obstetrical dates), race of the mother, gender, bronchopulmonary dysplasia (BPD) defined as an oxygen requirement for Z28 days, systemic dexamethasone therapy for BPD, intraventricular hemorrhage (IVH) grades II, III, or IV, clinical sepsis with culture-proven bacteremia or fungemia, and symptomatic patent ductus arteriosus (PDA) requiring surgical ligation or indomethacin therapy.
Results of all arterial blood gases (ABG) obtained during routine intermittent sampling throughout the first 30 days of life were extracted from hospital laboratory computer records. All were postductal samples obtained via indwelling umbilical artery catheters or peripheral arterial blood samples. We recorded arterial PO 2 (PaO 2 ), fraction of inspired oxygen (FiO 2 ), and the time each ABG was taken. The major focus of our investigation was PaO 2 fluctuation. We addressed this by measuring the coefficient of variation (CoV) (see Statistical Analysis) of the PaO 2 values at three time intervals for each infant: the first 5 days (n ¼ 231), first 10 days (n ¼ 164), and days 11 to 30 of oxygen therapy (n ¼ 100).
Statistical Analysis
For the descriptive and univariate analyses, the infants were categorized into five groups according to the ICROP and CRYO-ROP: immature retinal vessels with no clinical indication of ROP (which we will refer to as Stage 0), Stage 1, Stage 2 (see Study Design for definition), prethreshold, and threshold ROP. Continuous measures were expressed as mean±SD and compared between the ROP stages using analysis of variance, with proper adjustment for multiple pairwise comparisons. Categorical measures were expressed as percents and compared using w 2 tests of independence. Since the clinically relevant issue is the risk of threshold ROP versus prethreshold ROP or less, logistic regression was used to relate the risk of threshold ROP to PaO 2 fluctuation while adjusting for potential confounding factors. This also allows for the calculation of adjusted odds ratios and 95% confidence intervals. CoV was chosen for statistical analysis based upon previous work evaluating similar data of oxygen fluctuation. 22 The CoV expresses sample variability relative to the mean of the sample, and it is defined mathematically as the standard deviation divided by the mean. 28 This statistic was calculated for each infant using the multiple blood gas values obtained during each of the three oxygen therapy intervals. The statistical software package SAS was used for all statistical analyses. 29 
RESULTS
In total, 231 infants had their highest active stage of ROP documented. These infants had a mean birth weight of 1017.4±255.2 g and a mean gestational age of 27.4±2.8 weeks. In all, 63% were Caucasian and 55% were male. Table 1 summarizes clinical variables according to the degree of severity of ROP. Mean birth weight and gestational age were inversely related to ROP stage (p<0.001). BPD, postnatal steroid use, IVH, PDA, and sepsis were directly related to ROP stage (p<0.01).
During the first 30 days after birth, the 231 infants had 26,569 ABGs obtained, with an average of one ABG per infant every 2.4 hours. Blood gas data are presented in Table 2 . Remarkably, average PaO 2 was inversely related to ROP stage (p ¼ 0.005), while average FiO 2 was directly related to ROP stage (p ¼ 0.001). The ratio of average PaO 2 to average FiO 2 at the time of ABG sampling was used as a crude measure of lung function. [30] [31] [32] [33] As expected, this ratio was inversely related to ROP stage (p ¼ 0.003). Notably, the percent of hyperoxic episodes (measured as the percentage of PaO 2 above 80 mmHg) was inversely related to ROP stage (p<0.001). Mean CoV for 1 to 5 days of oxygen therapy was directly correlated to ROP stage using the five-level stratification (p ¼ 0.032). However, this correlation was not significant for the two later oxygen therapy intervals. Therefore, a two-level stratification was investigated (prethreshold or less versus threshold). Using the two-level stratification, the mean CoV was significantly larger, indicating more PaO 2 (Table 3) ). In a second two-level stratification combining prethreshold and threshold versus all stages less than prethreshold, associations of PaO 2 CoV and ROP stage vanished for all intervals (data not shown).
The CoV for all three time periods was directly related to the risk of developing threshold ROP based on logistic regression models (Table 3 ). After adjustment for gestational age and steroid use, a 10% increase in the CoV (approximately one SD (see Table 3 (Table 3) .
CONCLUSIONS
Given the multifactorial nature of ROP, the dissection of PaO 2 fluctuation from other strongly associated variables is not a trivial exercise. As expected, very low birth weight (VLBW) and gestational age make important independent contributions to the overall incidence of severe ROP. The smallest and most immature infants have the most immature and underdeveloped retinal vasculature. Immature retinal blood vessels may be more vulnerable to postnatal environmental influences such as hyperoxic or hypoxic tissue injury, hypercarbia, and metabolic acidosis. 13, 34 Moreover, these adverse conditions have a better opportunity to affect retinal vascular development if more development is left to occur under their influence.
Notable in the context of earlier theories correlating ROP outcome with hyperoxia, we found that the percent of hyperoxic episodes was inversely related to ROP stage (p<0.001). ROP has long been associated with the use of high-concentration supplemental oxygen therapy and with extended duration of oxygen use in the lowest birth-weight infants. 11, 35 Our curious finding regarding hyperoxic episodes might be partly explained by the fact that fragile infants can be difficult to saturate with oxygen, and those infants who improve rapidly often overshoot the target levels of saturation. However, the limited number of infants in this category argues against this as a complete explanation. Extended oxygen therapy is neither necessary nor sufficient to induce ROP, 12, 35, 36 A number of investigators have addressed this issue either retrospectively 20, 22 or anecdotally. 15 Cunningham performed a retrospective study comparing 31 infants with Stage 3 or greater ROP and 38 infants with no ROP or Stage 1 or 2. The study concluded that the variability of transcutaneous oxygen levels in the first 2 weeks of life was a significant predictor of severe ROP. 20 Saito et al. 22 evaluated 18 infants and found that the CoV for the fluctuation of blood gas tension in the group of infants with Stage 3 or 3 plus ROP was significantly elevated. Both reports supported an independent role for bloodstream oxygen fluctuations in the development of ROP, and the influence of oxygen fluctuation was greater within the first 2 weeks of life than it was at later times. Our findings are consistent with Saito's and Cunningham's previous work, which have implications for tighter control of oxygen therapy.
Generally, threshold ROP does not arise until about 38 weeks postmenstrual age. 37 One of the interesting implications of our data is that events in the first few days of life appear more important than events that occur later and closer to the time of the critical pathological retinal changes associated with threshold disease. Precisely how these early events predispose the retina to later pathologic changes is unknown, and to determine it is clearly beyond the scope of this project. However, the finding that PO 2 variation at later oxygen therapy intervals is not associated with threshold disease cannot be explained by the sample size in those experimental groups. In the restricted analysis, the 1 to 5 and 1 to 10 days intervals are still statistically significant whereas the 11 to 30 days interval is only suggestive (the 95% CI does not include 1, but the lower boundary is 0.95). Only if the earlier intervals were no longer statistically significant in the restricted analysis could sample size explain the absence of an association at the latest interval.
The nature of this project served to minimize the inherent limitations of retrospective studies. The analysis data were obtained during routine neonatal intensive care and no specific intervention protocols were used in the treatment of the infants included. Although caretakers could not be blinded to the general clinical course of the infants, ABG values were obtained only throughout the first 30 days of life. This is prior to the initial ROP examination that typically occurred at 5 weeks of age.
We observed a correlation when describing all five ROP stages and CoV as well as a strong statistical correlation with CoV and ROP when two-level stratification (prethreshold or less versus threshold) was employed. This is consistent with Saito et al.'s 22 study of 18 infants. In an attempt to discriminate the effect of the fluctuation of oxygen from the effects of other factors, we assessed confounding by gestational age, steroid use, birthweight, race, gender, BPD, IVH, PDA, sepsis, hyperoxia, hypoxia, and average PaO 2 to FiO 2. Gestational age and steroid use were the only covariates that had any appreciable confounding effect. The CoV for all three time periods evaluated were directly related to the risk of developing threshold ROP. This relationship was only strengthened when we restricted the analysis of all groups to infants receiving oxygen therapy during the 11 to 30 days interval that revealed an OR of 1.67.
The results of our study are promising in that attempting to better control infant PaO 2 fluctuations may lead to a decreased incidence of threshold ROP. The importance of PaO 2 fluctuations might be clarified with a prospective, randomized, placebocontrolled trial using an integrator that can adjust FiO 2 based on transcutaneous oxygen levels. In this way, an attempt can be made to decrease the fluctuation of PaO 2 by immediately adjusting FiO 2 in small increments to accommodate small increases or decreases in the transcutaneous oxygen level.
